Eric Weeks resumes & CV records
Resumes
Eric Weeks
Eric C Weeks, 61850 Arrowcreek Pkwy UNIT 21305, Reno, NV 89511
Eric Weeks Phones & Addresses
Reno, NV
Santa Rosa, CA
1256 Crespi Dr, Pacifica, CA 94044 650-7381303
1356 Crespi Dr, Pacifica, CA 94044 650-7381303
Mountain View, CA
San Mateo, CA
Palo Alto, CA
1356 Crespi Dr, Pacifica, CA 94044 650-3339419
Work
Company:
Design visionaries inc
Address:
7034 Calcaterra Dr, San Jose, CA 95120
Phones:
408-9976323
Position:
Senior manager
Industries:
Engineering Services
Education
Degree:
Associate degree or higher
Mentions for Eric C Weeks
Publications & IP owners
Us Patents
Composition And Dosage Form Comprising An Interferon Particle Formulation And Suspending Vehicle
US Patent:
7731947, Jun 8, 2010
Filed:
Nov 15, 2004
Appl. No.:
10/988716
Inventors:
Rom Ezer Eliaz - Sunnyvale CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Los Altos CA, US
Eric William Weeks - Hayward CA, US
Gunjan Junnarkar - Palo Alto CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Los Altos CA, US
Eric William Weeks - Hayward CA, US
Gunjan Junnarkar - Palo Alto CA, US
Assignee:
Intarcia Therapeutics, Inc. - Hayward CA
International Classification:
A61K 38/21
A61K 38/00
A61F 13/00
A61K 38/00
A61F 13/00
US Classification:
424 854, 424422, 514 12
Abstract:
A liquid composition in an osmotic drug delivery system and a dosage form in an osmotic drug delivery system is disclosed comprising an amphiphilic molecule, a non-aqueous liquid solvent, and a pharmaceutically active agent.
Composition And Dosage Form Comprising A Particle Formulation And Suspending Vehicle
US Patent:
7964183, Jun 21, 2011
Filed:
Dec 29, 2009
Appl. No.:
12/655397
Inventors:
Rom Ezer Eliaz - Sunnyvale CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Cupertino CA, US
Eric William Weeks - Oakland CA, US
Gunjan Junnarkar - Palo Alto CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Cupertino CA, US
Eric William Weeks - Oakland CA, US
Gunjan Junnarkar - Palo Alto CA, US
Assignee:
Intarcia Therapeutics, Inc. - Hayward CA
International Classification:
A61K 45/00
A61K 38/26
A61K 38/28
A61K 38/18
A61K 38/27
A61F 13/00
A61P 3/10
A61P 5/06
C07K 14/475
A61K 38/26
A61K 38/28
A61K 38/18
A61K 38/27
A61F 13/00
A61P 3/10
A61P 5/06
C07K 14/475
US Classification:
424 851, 424422, 514 59, 514 72, 514 76, 514 114
Abstract:
A liquid composition in an osmotic drug delivery system and a dosage form in an osmotic drug delivery system is disclosed comprising an amphiphilic molecule, a non-aqueous liquid solvent, and a pharmaceutically active agent.
Composition And Dosage Form Comprising A Particle Formulation And Suspending Vehicle
US Patent:
8257691, Sep 4, 2012
Filed:
Apr 20, 2011
Appl. No.:
13/090947
Inventors:
Rom Ezer Eliaz - Sunnyvale CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Cupertino CA, US
Eric William Weeks - Oakland CA, US
Gunjan Junnarkar - Palo Alto CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Cupertino CA, US
Eric William Weeks - Oakland CA, US
Gunjan Junnarkar - Palo Alto CA, US
Assignee:
Intarcia Therapeutics, Inc. - Hayward CA
International Classification:
A61K 45/00
A61K 38/26
A61K 38/28
A61K 38/18
A61K 38/27
A61F 13/00
A61P 3/10
A61P 5/06
C07K 14/475
A61K 38/26
A61K 38/28
A61K 38/18
A61K 38/27
A61F 13/00
A61P 3/10
A61P 5/06
C07K 14/475
US Classification:
424 851, 424422, 514 59, 514 72, 514 76, 514 114
Abstract:
A liquid composition in an osmotic drug delivery system and a dosage form in an osmotic drug delivery system is disclosed comprising an amphiphilic molecule, a non-aqueous liquid solvent, and a pharmaceutically active agent.
Particle Formulations For Use In Pharmaceutical Compositions
US Patent:
8398967, Mar 19, 2013
Filed:
Apr 21, 2011
Appl. No.:
13/091970
Inventors:
Rom Ezer Eliaz - San Rafael CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Los Altos CA, US
Eric William Weeks - Hayward CA, US
Gunjan Junnarkar - Palo Alto CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Los Altos CA, US
Eric William Weeks - Hayward CA, US
Gunjan Junnarkar - Palo Alto CA, US
Assignee:
Intarcia Therapeutics, Inc. - Hayward CA
International Classification:
A61K 38/21
A61K 9/00
A61K 38/00
A61P 3/10
C07K 14/605
A61K 9/00
A61K 38/00
A61P 3/10
C07K 14/605
US Classification:
424 854, 424400, 514 11, 514 117
Abstract:
A liquid composition in an osmotic drug delivery system and a dosage form in an osmotic drug delivery system is disclosed comprising an amphiphilic molecule, a non-aqueous liquid solvent, and a pharmaceutically active agent.
Suspending Vehicles And Pharmaceutical Suspensions For Drug Dosage Forms
US Patent:
2006021, Sep 28, 2006
Filed:
Jan 30, 2006
Appl. No.:
11/342445
Inventors:
Catherine Rohloff - Los Altos CA, US
Stephen Berry - Longview WA, US
Eric Weeks - Hayward CA, US
Stephen Berry - Longview WA, US
Eric Weeks - Hayward CA, US
International Classification:
A61K 48/00
A61K 38/28
A61K 38/31
A61K 38/30
A61K 38/21
A61K 38/20
A61K 38/19
A61K 38/18
A61K 38/22
A61K 38/17
A61L 9/04
A61K 38/28
A61K 38/31
A61K 38/30
A61K 38/21
A61K 38/20
A61K 38/19
A61K 38/18
A61K 38/22
A61K 38/17
A61L 9/04
US Classification:
424045000, 424085100, 424085200, 424085500, 424085600, 424085700, 424094100, 514012000, 514044000, 514003000
Abstract:
Suspending vehicles and pharmaceutical suspensions that include a biocompatible polymer that can be combined with a hydrophobic solvent and a hydrophilic solvent to provide vehicles and suspensions that are substantially free of stiff gels upon contact with an aqueous medium are provided. Vehicles and suspensions remain flowable out of a pump-driven dosage form over the life of the dosage form. Such vehicles and suspensions are also biocompatible, suitable for creating and maintaining drug suspensions, and capable of providing stable drug formulations.
Methods Of Manufacturing Viscous Liquid Pharmaceutical Formulations
US Patent:
2013005, Feb 28, 2013
Filed:
Aug 29, 2012
Appl. No.:
13/598405
Inventors:
Rom Ezer Eliaz - Sunnyvale CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Los Altos CA, US
Eric William Weeks - Hayward CA, US
Gunjan Junnarkar - Palo Alto CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Los Altos CA, US
Eric William Weeks - Hayward CA, US
Gunjan Junnarkar - Palo Alto CA, US
Assignee:
INTARCIA THERAPEUTICS, INC. - Hayward CA
International Classification:
A61K 47/10
C07C 29/00
C07D 207/12
C07D 311/72
C07F 9/02
A61K 38/02
A61K 38/21
A61K 38/18
A61K 38/19
A61K 39/395
A61K 38/27
A61K 38/25
A61K 38/28
A61K 9/14
A61K 47/14
A61K 47/46
A61K 47/22
C07C 67/00
C07C 29/00
C07D 207/12
C07D 311/72
C07F 9/02
A61K 38/02
A61K 38/21
A61K 38/18
A61K 38/19
A61K 39/395
A61K 38/27
A61K 38/25
A61K 38/28
A61K 9/14
A61K 47/14
A61K 47/46
A61K 47/22
C07C 67/00
US Classification:
424400, 560179, 568840, 568715, 548543, 549408, 568835, 568852, 554 78, 554227, 514 11, 424 855, 424 856, 424 857, 424 854, 514 88, 424 851, 4241331, 514 114, 514 112, 514 59, 514772, 514786, 514783, 514788
Abstract:
A liquid composition in an osmotic drug delivery system and a dosage form in an osmotic drug delivery system is disclosed comprising an amphiphilic molecule, a non-aqueous liquid solvent, and a pharmaceutically active agent.
Methods Of Manufacturing Viscous Liquid Pharmaceutical Formulations
US Patent:
2017031, Nov 9, 2017
Filed:
Jul 25, 2017
Appl. No.:
15/658965
Inventors:
- Boston MA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Los Altos CA, US
Eric William Weeks - Hayward CA, US
Gunjan Junnarkar - Palo Alto CA, US
Yuanpeng Zhang - Cupertino CA, US
Catherine Manya Rohloff - Los Altos CA, US
Eric William Weeks - Hayward CA, US
Gunjan Junnarkar - Palo Alto CA, US
International Classification:
A61K 9/00
A61K 31/519
A61K 38/21
A61K 9/16
A61K 9/16
A61K 9/107
A61K 31/519
A61K 38/21
A61K 9/16
A61K 9/16
A61K 9/107
Abstract:
A liquid composition in an osmotic drug delivery system and a dosage form in an osmotic drug delivery system is disclosed comprising an amphiphilic molecule, a non-aqueous liquid solvent, and a pharmaceutically active agent.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.